Alpha-Fetoprotein (AFP)

What is Alpha-Fetoprotein (AFP)?

Alpha-fetoprotein (AFP) is a protein primarily produced by the fetal liver during pregnancy. In adults, elevated AFP levels can indicate certain cancers or liver disease, while in pregnancy, abnormal levels may suggest fetal developmental issues. AFP is measured through a blood test and serves multiple clinical purposes depending on the patient population.

⚠️ Important: AFP Is Not Diagnostic on Its Own

AFP levels must always be interpreted alongside imaging findings, clinical presentation, and other laboratory values. Elevated AFP requires correlation with imaging (ultrasound, CT, MRI) and clinical context for diagnosis.

Primary uses

Tumor marker for liver cancer (HCC) and germ cell tumors
Prenatal screening for neural tube defects and chromosomal abnormalities
Liver disease monitoring

Sample type

Blood draw (venous sample). May also be measured in amniotic fluid during amniocentesis. Results reported in ng/mL or IU/mL (lab-dependent).

Often ordered with

LFTs (liver function tests), hCG (for germ cell tumors), imaging studies (ultrasound, CT, MRI), triple/quad screen in pregnancy.

Important

Reference ranges vary by age, pregnancy status, and laboratory. Prenatal AFP commonly reported as MoM (multiples of the median). Always interpret with clinical context.

Clinical Applications of AFP Testing

1. Tumor Marker (Oncology)

AFP is most commonly used as a tumor marker for:

Hepatocellular carcinoma (HCC): Primary liver cancer; AFP levels often markedly elevated (present in 50-70% of cases)
Germ cell tumors: Testicular cancer, ovarian cancer (nonseminomatous tumors)
Monitoring treatment response: Decreasing AFP suggests effective therapy; rising levels may indicate recurrence
Surveillance: High-risk patients (chronic hepatitis B/C, cirrhosis) often undergo surveillance with ultrasound and AFP, typically every 6 months, though practice varies by guideline and region

2. Prenatal Screening

During pregnancy (typically 15-20 weeks gestation), AFP is measured as part of maternal serum screening for risk assessment, not diagnosis:

Elevated AFP: May suggest increased risk for neural tube defects (spina bifida, anencephaly), abdominal wall defects, multiple gestation
Low AFP: Associated with increased risk of Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18)
Reporting method: Prenatal AFP is commonly reported as multiples of the median (MoM), adjusted for gestational age and maternal factors; cutoffs are lab-specific
Follow-up: Abnormal results typically prompt ultrasound examination for further evaluation and may lead to amniocentesis for amniotic fluid AFP measurement and definitive testing
Important: Maternal serum AFP is a screening tool that identifies pregnancies at higher risk, not a diagnostic test

💡 Clinical Pearl: Gestational Dating

Incorrect gestational dating is the most common cause of “abnormal” AFP results in pregnancy. Even a one-week error in dating can make AFP appear abnormal because levels fluctuate rapidly in the second trimester. Always confirm gestational age with ultrasound before interpreting results.

3. Liver Disease Assessment

AFP levels can be elevated in chronic liver disease and cirrhosis, even without cancer. Monitoring helps distinguish benign elevation from malignant transformation.

How to Interpret AFP Results (Clinically)

AFP Level	Possible Clinical Significance	Common Next Steps
Normal Adult Often <8–10 ng/mL (lab-dependent)	No evidence of AFP-producing tumor. Normal baseline in non-pregnant adults.	Routine follow-up based on clinical indication. Establish baseline for high-risk patients (chronic hepatitis, cirrhosis) for future surveillance.
Mildly Elevated 10-200 ng/mL	May indicate chronic liver disease, hepatitis, cirrhosis. Small possibility of early HCC or germ cell tumor.	Depending on risk factors and symptoms: liver imaging (ultrasound, CT, or MRI), repeat AFP in 1-3 months if chronic liver disease present, correlate with liver function tests and clinical history.
Moderately Elevated 200-400 ng/mL	Raises concern for hepatocellular carcinoma or germ cell tumor. Can also occur with severe hepatitis or liver regeneration.	Urgent imaging (triphasic CT or MRI) based on clinical context, consultation with oncology/hepatology, consider biopsy if mass identified and diagnosis uncertain.
Markedly Elevated >400 ng/mL	Raises strong concern for AFP-producing malignancy (HCC or metastatic germ cell tumor). Requires correlation with imaging and clinical context for diagnosis.	Immediate oncology referral in appropriate clinical context, comprehensive imaging, staging workup, multidisciplinary tumor board discussion, treatment planning. Note: AFP alone is not diagnostic; imaging confirmation essential.
Pregnancy (2nd Trimester) Reported as MoM; variable by gestational age	High AFP (MoM): neural tube defects, abdominal wall defects, multiple gestation, incorrect dating. Low AFP (MoM): chromosomal abnormalities (Down syndrome, trisomy 18), incorrect dating.	Detailed ultrasound anatomy scan, confirm gestational age with ultrasound, genetic counseling, consider amniocentesis for amniotic fluid AFP if high-risk findings or patient preference.

⚠️ Important Interpretation Notes

AFP levels must be interpreted with imaging findings, clinical presentation, and other laboratory values
Benign causes of elevated AFP include hepatitis, cirrhosis, pregnancy, and liver regeneration
Serial AFP measurements are more valuable than single values for monitoring treatment response
Different labs use different reference ranges and units (ng/mL vs IU/mL) and different MoM cutoffs—always use lab-specific reference intervals
AFP is supportive/adjunctive in HCC diagnosis; modern diagnosis relies on multiphase imaging criteria in at-risk patients

Nursing Considerations (Practical)

👩‍⚕️ What I watch for at the bedside

Timing in pregnancy: Maternal AFP is typically drawn between 15-20 weeks gestation for optimal screening accuracy. Confirm gestational age with ultrasound before interpreting results—incorrect dating is the #1 cause of “abnormal” AFP.
Patient anxiety: AFP results, especially in pregnancy, can cause significant distress. Provide clear education that abnormal results require follow-up testing, not immediate diagnosis.
Oncology context: For patients with known or suspected cancer, explain that AFP is one piece of the diagnostic puzzle and will be interpreted alongside imaging and other tests.
Sample handling: Use standard venipuncture technique. No special preparation typically required, but verify lab-specific requirements.
Trending values: Serial AFP measurements are critical in cancer monitoring. Ensure consistent timing and same-laboratory testing when possible for accurate comparison.
Surveillance protocols: High-risk patients with chronic liver disease often undergo AFP testing with ultrasound, typically every 6 months as part of HCC surveillance, though protocols may vary by institution and guideline.

🚨 Escalate if you observe

Markedly elevated AFP (>400 ng/mL) with new abdominal symptoms, weight loss, or jaundice in at-risk patient
Rising AFP levels in patient being monitored for known cancer (suggests progression or recurrence)
Pregnant patient with abnormal AFP and concerning ultrasound findings
Patient with chronic liver disease and rapidly increasing AFP (concern for HCC development)
New testicular or pelvic mass with elevated AFP in young adult

Common Causes of Elevated AFP

Malignant Causes

Hepatocellular carcinoma (HCC): Most common malignant cause; 50-70% of HCC cases have elevated AFP
Germ cell tumors: Testicular cancer (nonseminomatous), ovarian cancer (yolk sac tumors, embryonal carcinoma)
Gastric cancer: Rare AFP-producing gastric adenocarcinoma
Metastatic disease: Particularly from hepatic metastases of colon or pancreatic cancer

Benign Causes (Non-Cancer)

Chronic hepatitis: Hepatitis B or C infection with active inflammation
Cirrhosis: Any cause of cirrhosis can cause mild-moderate AFP elevation
Acute liver injury: Drug-induced liver injury, acute viral hepatitis, ischemic hepatitis
Liver regeneration: Following liver resection or transplant
Pregnancy: Normal physiologic elevation during gestation
Hereditary tyrosinemia: Rare metabolic disorder

Causes of Abnormal AFP in Pregnancy

Elevated maternal serum AFP: Neural tube defects (spina bifida, anencephaly), abdominal wall defects (gastroschisis, omphalocele), multiple gestation, incorrect gestational dating (most common), fetal demise
Low maternal serum AFP: Chromosomal abnormalities (Down syndrome, trisomy 18), incorrect gestational dating, molar pregnancy

Sample Collection & Patient Preparation

Before the Test

Fasting: Generally not required for AFP testing, but verify with ordering provider if other tests are being drawn simultaneously
Medication review: No medications typically interfere with AFP; continue all prescribed medications unless otherwise instructed
Pregnancy dating: For prenatal AFP, accurate gestational age is critical for interpretation. Confirm dating with ultrasound if uncertain—incorrect dating is the most common cause of abnormal results
Patient education: Explain the purpose of the test, timeline for results, and that abnormal results require additional testing for confirmation

During Collection

Standard venipuncture: Collect blood sample using appropriate tube (typically serum separator tube – SST/gold top)
Sample volume: Usually 3-5 mL of blood; verify specific lab requirements
Prevent hemolysis: Use gentle technique, avoid vigorous shaking, ensure proper needle size
Labeling: Accurately label specimen with patient name, date of birth, date/time of collection. For pregnancy AFP, include gestational age
Alternative sample: AFP can also be measured in amniotic fluid during amniocentesis for more definitive prenatal diagnosis when indicated

After Collection

Apply pressure: Ensure hemostasis at puncture site, particularly in patients on anticoagulation
Transport promptly: Send to laboratory according to facility protocol; serum should be separated within specified timeframe
Document: Record collection time, patient tolerance, and any complications
Follow-up plan: Inform patient when and how results will be communicated; provide contact information for questions

❓ Frequently Asked Questions (FAQ)

1. What does a high AFP level mean?

Elevated AFP can indicate liver cancer, germ cell tumors, or benign liver conditions like hepatitis or cirrhosis. In pregnancy, it may suggest neural tube defects. The significance depends on the degree of elevation and clinical context.

2. Can AFP be elevated without cancer?

Yes. Benign causes include chronic hepatitis, cirrhosis, acute liver injury, pregnancy, and liver regeneration. Mild elevations (10-100 ng/mL) can be from non-cancerous conditions, but must be interpreted with risk factors, imaging, and clinical context.

3. Is AFP used to screen for liver cancer?

AFP combined with ultrasound is commonly used for surveillance in high-risk patients (chronic hepatitis B or C, cirrhosis), typically every 6 months, but not for general population screening. Practice varies by guideline and region. AFP has limitations in sensitivity and specificity, which is why imaging is essential.

4. What happens if my prenatal AFP is abnormal?

Abnormal prenatal AFP triggers additional testing, typically a detailed ultrasound anatomy scan. Note that incorrect gestational dating is the most common cause of abnormal AFP results in pregnancy. Genetic counseling may be offered, and amniocentesis might be recommended depending on findings and patient preferences.

5. How often is AFP checked in cancer patients?

Frequency depends on the cancer type and treatment phase. During active treatment, AFP may be checked monthly or quarterly. After remission, surveillance intervals typically extend to every 3-6 months. For high-risk surveillance in chronic liver disease, ultrasound with AFP is typically performed every 6 months.

6. Do I need to fast for an AFP test?

Fasting is generally not required for AFP. However, if other tests requiring fasting are ordered simultaneously, follow those instructions.

7. Can medications affect AFP levels?

Most medications do not significantly affect AFP levels. However, treatments for liver disease or cancer can influence results. Continue prescribed medications unless specifically instructed otherwise.

8. What is a normal AFP level?

In non-pregnant adults, normal AFP is typically less than 8-10 ng/mL, though reference ranges vary by laboratory. Pregnancy values vary significantly by gestational age and are commonly reported as multiples of the median (MoM) with lab-specific adjustments.

9. Can AFP detect all liver cancers?

No. Only 50-70% of hepatocellular carcinomas produce elevated AFP. Some liver cancers never elevate AFP, which is why imaging (ultrasound, CT, MRI) is essential for comprehensive evaluation.

10. How long does it take to get AFP results?

AFP results are typically available within 24-72 hours, depending on the laboratory. Stat/urgent requests may be processed more quickly in emergency situations.

📚 References

[1] National Cancer Institute. Tumor Markers in Common Use. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-list

[2] American Association for Clinical Chemistry (AACC). Alpha-Fetoprotein (AFP) Tumor Marker Test. https://www.testing.com/tests/alpha-fetoprotein-afp-tumor-marker/

[3] American College of Obstetricians and Gynecologists. Screening for Fetal Chromosomal Abnormalities. Practice Bulletin No. 226. Obstet Gynecol. 2020.

[4] Heimbach JK, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018.

[5] MedlinePlus (NLM). Alpha-fetoprotein (AFP) tumor marker test. https://medlineplus.gov/lab-tests/alpha-fetoprotein-afp-tumor-marker-test/

[6] Mayo Clinic Laboratories. Alpha-Fetoprotein (AFP), Serum. https://www.mayocliniclabs.com/test-catalog/overview/8524

[7] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018.

[8] NCBI Bookshelf (NIH). StatPearls: Alpha Fetoprotein. https://www.ncbi.nlm.nih.gov/books/NBK539818/